• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > La Merie Publishing
Publisher
Filter

La Merie Publishing Report List

La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company. The focus of our reports and subscription services such as databases and periodicals is directed towards biologs as therapeutics, such as antibodies, proteins, peptides, vaccines and biosimilars. Today we continue to publish reports, but leverage our experience, knowledge and report writing expertise to offer this service to individual customers.

Filter
Title Search
1 - 25 of 28 Products Sort by Display
4 Reports Bundle: Immuno-Oncology - Inhibitory and Stimulatory Immunomodulators
Published by
La Merie Publishing
Product code
408112
Published
July 26, 2018
Content info
455 Pages
Price
USD 1690
Sample available
6 Reports Bundle: Immunotherapeutics Targeting MAGE-A, NY-ESO-1, hTERT, WT1, PRAME and Survivin
Published by
La Merie Publishing
Product code
651129
Published
June 12, 2018
Content info
 
Price
USD 955
Sample available
2 Reports Bundle: TCR-Based Antibody and T-Cell Immunotherapy
Published by
La Merie Publishing
Product code
651128
Published
May 31, 2018
Content info
 
Price
USD 3505
Sample available
TCR Engineered T-Cell Therapy 2018: An Industry Analysis of Technologies, Pipelines, Stakeholders & Deals
Published by
La Merie Publishing
Product code
642119
Published
May 20, 2018
Content info
294 Pages
Price
USD 2500
Sample available
Intracellular Targets Made Druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: An Industry Analysis of Technologies, Stakeholders, Deals & Trends
Published by
La Merie Publishing
Product code
600758
Published
January 22, 2018
Content info
251 Pages
Price
USD 2800
Sample available
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - 2017 Update
Published by
La Merie Publishing
Product code
358307
Published
November 2, 2017
Content info
58 Pages
Price
USD 525
Sample available
2 Reports Bundle: Immunotherapy with Oncolytic Viruses and mRNA Vaccines & Therapeutics
Published by
La Merie Publishing
Product code
579795
Published
October 23, 2017
Content info
 
Price
USD 3600
Sample available
mRNA Vaccines & Therapeutics 2017: An Industry Analysis of Technologies, Pipelines, Stakeholders and Deals
Published by
La Merie Publishing
Product code
518829
Published
June 22, 2017
Content info
260 Pages
Price
USD 2520
Sample available
The Oncolytic Virus Landscape 2017: An Analysis of Pipeline, Stakeholders, Deals, Industry Trends & Opportunities
Published by
La Merie Publishing
Product code
425869
Published
January 26, 2017
Content info
225 Pages
Price
USD 2400
Sample available
Antibody-Drug Conjugate Pipeline Review By Target, Drug, Phase and Company
Published by
La Merie Publishing
Product code
225677
Published
December 19, 2016
Content info
288 Pages
Price
USD 880
Sample available
3 Reports Bundle: Hot Targets for Empowered Antibody and Cell Therapy Technologies
Published by
La Merie Publishing
Product code
408113
Published
December 8, 2016
Content info
202 Pages
Price
USD 1254
Sample available
2 Reports Bundle: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-Cells (Two Reports released in 2016)
Published by
La Merie Publishing
Product code
368816
Published
September 1, 2016
Content info
 
Price
USD 3400
Sample available
B-Cell Maturation Antigen (BCMA): Hot Target for Emerging Treatment Modalities
Published by
La Merie Publishing
Product code
369011
Published
August 31, 2016
Content info
39 Pages
Price
USD 570
Sample available
CD123: A Paradigmatic Target for Immunotherapeutic Treatment Modalities
Published by
La Merie Publishing
Product code
369010
Published
August 31, 2016
Content info
83 Pages
Price
USD 800
Sample available
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of Technologies Opens Business Opportunities Beyond CD19 CARTs
Published by
La Merie Publishing
Product code
366651
Published
August 7, 2016
Content info
388 Pages
Price
USD 2750
Sample available
*
Published by
La Merie Publishing
Product code
359751
Published
June 9, 2016
Content info
 
Price
USD 3500
Sample available
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
Published by
La Merie Publishing
Product code
327820
Published
May 25, 2016
Content info
462 Pages
Price
USD 1450
Sample available
T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals
Published by
La Merie Publishing
Product code
357780
Published
May 11, 2016
Content info
230 Pages
Price
USD 2400
Sample available
RORgamma Modulators 2016: A Comparative Analysis of the Landscape of RORgamma Antagonists and Agonists
Published by
La Merie Publishing
Product code
351304
Published
February 3, 2016
Content info
88 Pages
Price
USD 1050
Sample available
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - A Pipeline, Technology, Stakeholder & Business Analysis
Published by
La Merie Publishing
Product code
294276
Published
November 30, 2015
Content info
470 Pages
Price
USD 2500
Sample available
Engineered TCR and CAR Immunotherapeutics 2015
Published by
La Merie Publishing
Product code
325905
Published
March 13, 2015
Content info
201 Pages
Price
USD 2630
Sample available
Recombinant Coagulation Factors 2015: Maturation of Recombinant Clotting Factor Pipeline and Emergence of Gene Therapy and Alternative Procoagulants
Published by
La Merie Publishing
Product code
274454
Published
December 22, 2014
Content info
210 Pages
Price
USD 2795
Sample available
Botulinum Neurotoxins: A Comparative Industry Analysis of Products, Pipelines, Technologies and Stakeholders
Published by
La Merie Publishing
Product code
308429
Published
July 18, 2014
Content info
169 Pages
Price
USD 2459
Sample available
Competitor Analysis: Cancer Vaccines
Published by
La Merie Publishing
Product code
221876
Published
March 24, 2014
Content info
179 Pages
Price
USD 1112
Sample available
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
Published by
La Merie Publishing
Product code
288582
Published
October 25, 2013
Content info
84 Pages
Price
USD 1829
Sample available